Our Expertise

DR Consulting develops global insight into the key value drivers for providers, payers, and patients that power acceptance of therapies, enable commercial differentiation, and optimize return throughout the product lifecycle and across the portfolio.

We develop value strategies founded in evidence-based differentiation for core stakeholders in the biopharmaceutical industry. Our expertise lies in connecting and applying insight into the scientific, clinical, economic, and patient-centric outcomes, evidence, and perceptions that inform commercial value, starting from the earliest stages of development and continuing through regulatory approval, product launch, and lifecycle management.

Global Experience

Our experience spans:

• The top pharmaceutical markets: US, UK, France, Germany, Italy, Spain, Japan
• The top emerging markets: Brazil, Russia, India, China
• And beyond: Latin America, Asia, etc.

Broad Industry Expertise

We have biopharmaceutical, device, and diagnostic expertise in all
of the therapeutic areas covered by our companies, which span:

Oncology Cardiovascular Central Nervous System & Pain Management Infectious Disease Immune & Inflammatory Metabolic Disorders

Respiratory Disorders Genitourinary Gastrointestinal Nephrology Orthopedics Dentistry and Orthodontics Aesthetics

We also have extensive project experience working in orphan indications and targeted patient segments. Some of the areas in which we have worked recently include:

Amyloidosis Amyotrophic Lateral Sclerosis (ALS) Bone and Muscle Healing Burn Recovery Cystic Fibrosis Eosinophilic Esophagitis Ewing’s Sarcoma Hereditary Angioedema Idiopathic Pulmonary Fibrosis MRSA Infections

Muscular Dystrophy M. pneumoniae or “Walking Pneumonia” Patients with Very High LDL-C P. aeruginosa Infections Pulmonary Arterial Hypertension Systemic Lupus Erythematosus and Lupus Nephritis Von Willebrand Disease